James W. Schurr

Incidence of Sepsis and Mortality With Prior Exposure of HMG-COA Reductase Inhibitors in a Surgical Intensive Care Population

James W. Schurr, Wenchen Wu, Alexandria Smith-Hannah et al. · Shock · 2015 · 21 citations

Inflammation, Critical Care Medicine, Hmg-coa Reductase Inhibitors +15

Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated Heparin

Clara Ting, Katelyn W. Sylvester, James W. Schurr · Clinical and Applied Thrombosis/Hemostasis · 2018 · 19 citations · Full text

Description and Evaluation of the Implementation of a Weight-Based, Nurse-Driven Heparin Nomogram in a Tertiary Academic Medical Center

James W. Schurr, Craig A. Stevens, Anne Bane et al. · Clinical and Applied Thrombosis/Hemostasis · 2017 · 18 citations · Full text

Clinical Specialties, Pharmacotherapy, Minimum Threshold Value +24

Intravenous Immune Globulin Stewardship Program at a Tertiary Academic Medical Center

Megan A. Rocchio, James W. Schurr, Aaron P. Hussey et al. · Annals of Pharmacotherapy · 2016 · 17 citations

Survival and Outcomes After Cardiac Arrest With VA-ECMO Rescue Therapy

James W. Schurr, Mohammad Noubani, Lee Ann Santore et al. · Shock · 2021 · 13 citations